Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Sep-24 9:20 PM View:  | Travere Therapeutics, Inc. (TVTX) | 09-Sep-24 | Sale (Planned) | 21,125 | $11.52 | $243,360.00 | (6%) 383.1K to 361.98K | |
| 09-Sep-24 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-24 | Grant | 32,500 | -- | -- | 9% 350.6K to 383.1K | |
| 02-Feb-24 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 9,106 | $8.53 | $77,693.30 | (2%) 369.72K to 360.62K | |
| 02-Feb-24 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale (Planned) | 10,016 | $8.86 | $88,741.80 | (3%) 360.62K to 350.6K | |
| 02-Feb-24 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 135,000 | -- | -- | 58% 234.72K to 369.72K | |
| 25-Jan-24 4:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Jan-24 | Sale (Planned) | 7,873 | $8.96 | $70,542.10 | (3%) 242.59K to 234.72K | |
| 05-Sep-23 8:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-23 | Sale (Planned) | 4,455 | $14.71 | $65,533.10 | (2%) 247.05K to 242.59K | |
| 05-Sep-23 8:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Aug-23 | Grant | 9,900 | -- | -- | 4% 237.15K to 247.05K | |
| 02-Feb-23 6:58 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-23 | Sale (Planned) | 8,196 | $22.25 | $182,361.00 | (3%) 245.35K to 237.15K | |
| 02-Feb-23 6:58 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 97,500 | -- | -- | 66% 147.85K to 245.35K | |
| 26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-23 | Sale (Planned) | 6,442 | $21.50 | $138,503.00 | (4%) 154.29K to 147.85K | |
| 06-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Jan-23 | Sale (Planned) | 5,625 | $20.75 | $116,719.00 | (4%) 159.91K to 154.29K | |
| 11-Feb-22 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Feb-22 | Market Sale (Planned) | 4,832 | $27.84 | $134,523.00 | (3%) 164.75K to 159.91K | (< 1%) |
| 02-Feb-22 4:16 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Grant | 37,848 | -- | -- | 29% 131.71K to 169.56K | |
| 02-Feb-22 4:16 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Sale (Planned) | 4,813 | $27.40 | $131,876.00 | (3%) 169.56K to 164.75K | |
| 26-Jan-22 4:33 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-22 | Market Sale (Planned) | 7,873 | $24.98 | $196,668.00 | (6%) 139.58K to 131.71K | (12%) |
| 06-Jan-22 4:03 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Jan-22 | Market Sale (Planned) | 12,500 | $29.95 | $374,369.00 | (8%) 152.08K to 139.58K | 2% |
| 06-Jan-22 4:03 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Jan-22 | Market Sale (Planned) | 4,832 | $30.43 | $147,038.00 | (3%) 156.91K to 152.08K | (< 1%) |
| 17-Aug-21 7:40 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-Aug-21 | Market Sale | 7,836 | $17.12 | $134,142.00 | (5%) 164.75K to 156.91K | |
| 17-Aug-21 7:40 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Aug-21 | Grant | 17,500 | -- | -- | 12% 147.25K to 164.75K | |
| 03-Jun-21 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Jun-21 | Market Sale (Planned) | 4,780 | $14.35 | $68,593.00 | (3%) 152.03K to 147.25K | < 1% |
| 03-Jun-21 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Jun-21 | Market Sale (Planned) | 4,782 | $14.89 | $71,204.00 | (3%) 156.81K to 152.03K | 3% |
| 09-Feb-21 4:28 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-21 | Market Sale (Planned) | 4,813 | $31.58 | $151,995.00 | (3%) 161.63K to 156.81K | 2% |
| 09-Feb-21 4:28 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Feb-21 | Market Sale (Planned) | 4,813 | $31.41 | $151,176.00 | (3%) 166.44K to 161.63K | (1%) |
| 05-Feb-21 4:46 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Grant | 17,500 | -- | -- | 12% 148.94K to 166.44K | |
| 03-Feb-21 9:29 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Market Sale (Planned) | 2,406 | $28.91 | $69,557.50 | (2%) 151.34K to 148.94K | < 1% |
| 02-Feb-21 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale | 6,328 | $29.60 | $187,282.00 | (4%) 160.08K to 153.75K | |
| 02-Feb-21 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale (Planned) | 2,406 | $30.75 | $73,984.50 | (2%) 153.75K to 151.34K | |
| 02-Feb-21 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-21 | Grant | 15,000 | -- | -- | 10% 145.08K to 160.08K | |
| 25-Jan-21 8:54 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Jan-21 | Grant | 57,260 | -- | -- | 65% 87.82K to 145.08K | |
| 07-Jan-21 6:29 PM View: | Travere Therapeutics, Inc. (TVTX) | 06-Jan-21 | Market Sale (Planned) | 3,438 | $27.01 | $92,860.40 | (4%) 91.26K to 87.82K | < 1% |
| 07-Jan-21 6:29 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Jan-21 | Market Sale (Planned) | 3,438 | $26.65 | $91,622.70 | (4%) 94.69K to 91.26K | (1%) |
| 22-Sep-20 9:15 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Sep-20 | Market Sale | 10,805 | $19.28 | $208,319.00 | (10%) 105.5K to 94.69K | |
| 22-Sep-20 9:15 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Sep-20 | Grant | 28,000 | -- | -- | 36% 77.5K to 105.5K | |
| 31-Jan-20 8:14 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-20 | Grant | 35,000 | -- | -- | 82% 42.5K to 77.5K | |
| 08-Jan-20 8:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Jan-20 | Market Sale (Planned) | 3,750 | $15.14 | $56,775.00 | (8%) 46.25K to 42.5K | |
| 08-Jan-20 8:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 07-Jan-20 | Market Sale (Planned) | 3,750 | $13.94 | $52,275.00 | (8%) 50.0K to 46.25K | |
| 08-Jan-19 5:25 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Jan-19 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K |